These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32058256)
1. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis - Real-time assessment by isothermal microcalorimetry. Gonzalez Moreno M; Butini ME; Maiolo EM; Sessa L; Trampuz A Colloids Surf B Biointerfaces; 2020 May; 189():110853. PubMed ID: 32058256 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of different bioactive glass S53P4 formulations in biofilm eradication and the impact of pH and osmotic pressure. Müller N; Kollert M; Trampuz A; Gonzalez Moreno M Colloids Surf B Biointerfaces; 2024 Jul; 239():113940. PubMed ID: 38744081 [TBL] [Abstract][Full Text] [Related]
3. The in vitro antibacterial effect of S53P4 bioactive glass and gentamicin impregnated polymethylmethacrylate beads. Gergely I; Zazgyva A; Man A; Zuh SG; Pop TS Acta Microbiol Immunol Hung; 2014 Jun; 61(2):145-60. PubMed ID: 24939683 [TBL] [Abstract][Full Text] [Related]
4. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection. Cunha MT; Murça MA; Nigro S; Klautau GB; Salles MJC BMC Infect Dis; 2018 Apr; 18(1):157. PubMed ID: 29614973 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro. Coraça-Huber DC; Fille M; Hausdorfer J; Putzer D; Nogler M J Orthop Res; 2014 Jan; 32(1):175-7. PubMed ID: 24108602 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Growth Reduction of Five Clinical Pathogens by Injectable S53P4 Bioactive Glass Material Formulations. Thijssen EGJ; van Gestel NAP; Bevers R; Hofmann S; Geurts J; van Loo IHM; Arts JJ Front Bioeng Biotechnol; 2020; 8():634. PubMed ID: 32676498 [TBL] [Abstract][Full Text] [Related]
7. Antibiofilm agents against MDR bacterial strains: is bioactive glass BAG-S53P4 also effective? Bortolin M; De Vecchi E; Romanò CL; Toscano M; Mattina R; Drago L J Antimicrob Chemother; 2016 Jan; 71(1):123-7. PubMed ID: 26462989 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity and resistance selection of different bioglass S53P4 formulations against multidrug resistant strains. Drago L; De Vecchi E; Bortolin M; Toscano M; Mattina R; Romanò CL Future Microbiol; 2015; 10(8):1293-9. PubMed ID: 26228640 [TBL] [Abstract][Full Text] [Related]
9. BAG-S53P4 as bone graft extender and antimicrobial activity against gentamicin- and vancomycin-resistant bacteria. Bortolin M; Romanò CL; Bidossi A; Vecchi E; Mattina R; Drago L Future Microbiol; 2018 Apr; 13():525-533. PubMed ID: 29521127 [TBL] [Abstract][Full Text] [Related]
10. Clinical applications of Bioactive glass S53P4 in bone infections: a systematic review. Bigoni M; Turati M; Zanchi N; Lombardo AS; Graci J; Omeljaniuk RJ; Zatti G; Gaddi D Eur Rev Med Pharmacol Sci; 2019 Apr; 23(2 Suppl):240-251. PubMed ID: 30977891 [TBL] [Abstract][Full Text] [Related]
11. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study. Drago L; Romanò D; De Vecchi E; Vassena C; Logoluso N; Mattina R; Romanò CL BMC Infect Dis; 2013 Dec; 13():584. PubMed ID: 24325278 [TBL] [Abstract][Full Text] [Related]
12. Dentin enhances the effectiveness of bioactive glass S53P4 against a strain of Enterococcus faecalis. Zehnder M; Waltimo T; Sener B; Söderling E Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):530-5. PubMed ID: 16545719 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial effects of glass ionomer cements containing bioactive glass (S53P4) on oral micro-organisms in vitro. Yli-Urpo H; Närhi T; Söderling E Acta Odontol Scand; 2003 Aug; 61(4):241-6. PubMed ID: 14582593 [TBL] [Abstract][Full Text] [Related]
14. The Use of Bioactive Glass S53P4 as Bone Graft Substitute in the Treatment of Chronic Osteomyelitis and Infected Non-Unions - a Retrospective Study of 50 Patients. Malat TA; Glombitza M; Dahmen J; Hax PM; Steinhausen E Z Orthop Unfall; 2018 Apr; 156(2):152-159. PubMed ID: 29665602 [TBL] [Abstract][Full Text] [Related]
15. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Lindfors NC; Hyvönen P; Nyyssönen M; Kirjavainen M; Kankare J; Gullichsen E; Salo J Bone; 2010 Aug; 47(2):212-8. PubMed ID: 20624692 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides. Ozden S; Karataş H; Yildiz S; Göker H Arch Pharm (Weinheim); 2004 Oct; 337(10):556-62. PubMed ID: 15476288 [TBL] [Abstract][Full Text] [Related]
17. Preliminary evaluation of bioactive glass S53P4 as an endodontic medication in vitro. Zehnder M; Söderling E; Salonen J; Waltimo T J Endod; 2004 Apr; 30(4):220-4. PubMed ID: 15085050 [TBL] [Abstract][Full Text] [Related]
18. Bioactive glass S53P4 eradicates Grønseth T; Vestby LK; Nesse LL; von Unge M; Silvola JT Ups J Med Sci; 2020 Aug; 125(3):217-225. PubMed ID: 32552165 [No Abstract] [Full Text] [Related]
19. Antimicrobial effectiveness of polyhexamethylene biguanide on Enterococcus faecalis, Staphylococcus epidermidis and Candida albicans. Medvedec Mikić I; Cigić L; Kero D; Kalibović Govorko D; Prpić Mehičić G; Tambić Andrašević A; Simeon P Med Glas (Zenica); 2018 Aug; 15(2):132-138. PubMed ID: 30047541 [TBL] [Abstract][Full Text] [Related]
20. Interactions between the bioactive glass S53P4 and the atrophic rhinitis-associated microorganism klebsiella ozaenae. Stoor P; Söderling E; Grenman R J Biomed Mater Res; 1999; 48(6):869-74. PubMed ID: 10556853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]